Compare · EUCR vs PRE
EUCR vs PRE
Side-by-side comparison of Eucrates Biomedical Acquisition Corp. (EUCR) and Prenetics Global Limited (PRE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUCR and PRE operate in Blank Checks (Finance), so they compete in similar markets.
- PRE carries a market cap of $279.6M.
- PRE has hit the wire 7 times in the past 4 weeks while EUCR has been quiet.
- PRE has more recent analyst coverage (8 ratings vs 0 for EUCR).
EUCR
Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest EUCR
- SEC Form 15-12G filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 25-NSE filed by Eucrates Biomedical Acquisition Corp.
- SEC Form 10-K filed by Eucrates Biomedical Acquisition Corp.
- Reported Late Tuesday April 11, Eucrates Biomedical Acquisition Corp. Announces Liquidation; Co To Redeem All Outstanding Shares At A Per-Share Redemption Price Of ~$10
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Eucrates Biomedical Acquisition Corp. Announces Liquidation
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
- SEC Form NT 10-K filed by Eucrates Biomedical Acquisition Corp.
- Eucrates Biomedical Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Eucrates Biomedical Acquisition Corp. (Amendment)
Latest PRE
- Director Leogrande Hudson Blake converted options into 2,000 units of Class A Ordinary Share, increasing direct ownership by 25% to 10,001 units (SEC Form 4)
- SEC Form 6-K filed by Prenetics Global Limited
- Care Bears And Prenetics' IM8 Announce Global Partnership
- SEC Form 6-K filed by Prenetics Global Limited
- Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
- SEC Form 6-K filed by Prenetics Global Limited
- Maxim Group initiated coverage on Prenetics Group Ltd. with a new price target
- SEC Form 6-K filed by Prenetics Global Limited
- IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
- SEC Form 4 filed by Prenetics Global Limited